Sun Pharmaceutical Industries’ Halol unit has received clearance from the UK’s pharma regulatory body, reported a leading news daily.
The company has got clearance for good manufacturing practices as directed by the UK’s Medicines and Healthcare Products Regulatory Agency, said the report. However, Sun Pharma has not commented on the report.
The company’s Halol manufacturing unit has faced regulatory issues from the U.S. Food and Drug Administration (USFDA). In December 2016, USFDA had issued a warning letter to the plant for failing to prevent microbiological contamination.